In pharmaceutical marketing, a little goes a long way
A new study shows that in pharmaceutical marketing, the number of doctors you target may matter more than the amount of money you give them. More
Belief and evidence: How framing health news matters
Gina Kolata misrepresents the debate on tPA for strokes by painting the issue as evidence versus belief. More
Hidden influence: Financial conflicts you might have missed
Recent conflicts of interest in medicine and health policy you probably missed... More
Industry payments to doctors: Opioids are the tip of the iceberg
A closer look at the hundreds of millions that pharma spends on payments to physicians. More
Industry payments to doctors: Opioids are the tip of the iceberg
A closer look at the hundreds of millions that pharma spends on payments to physicians. More
Conflicts of interest complicate Hep C research debate
Researchers and advocates are up in arms over a new review of Hepatitis C treatments. But look who's funding each side... More